AIDS Weekly and Law

Bristol-Myers Squibb Company - Data support bioequivalence for fixed-dose regimen of Sustiva and Truvada as HIV treatment

Dr. Margarete Fischer Bosch Institute for Clinical Pharmacology, Stuttgart - CYP2B6 genetic variability determined for populations of African and Asian origin

Flinders Medical Center, Bedford Park - Boosted indinavir plus efavirenz yields durable response in patients failing NRTI regimens

MedMira Inc. - European Patent Office grants diagnostics company patent for HCV Mosaic Antigen

Montefiore Medical Center, Bronx - Age and markers of functional status predict mortality in advanced AIDS

Arizona State University - Researchers' strategy on vaccine development is to stop HIV virus before it enters the body

Cameroon Baptist Convent Health Board, Flagstaff - Prevention of mother-to-child HIV transmission integrated into routine antenatal care

Chelsea & Westminster Hospital, London - HAART efficacy and toxicity widely variable between HIV-infected patients

Chelsea & Westminster Hospital, London - Risk factors identified for hypercholesterolemia risk at HAART initiation

Chiang Mai University - Long-term zidovudine prophylaxis reduces HIV-1 vertical transmission to neonates

Children, Youth, and Women's Health Service, Adelaide - Report describes optimization of multipartite HIV-based vector system

CIBO, Jalisco - Drug-resistance mutations identified in HAART-naive HIV-infected patients

Fred Hutchinson Cancer Research Center, Seattle - Recent findings in HIV/AIDS pathogenesis provide new insights

Harvard University - Clinical algorithm predicts early HIV-1 infection

Health Canada - Health Canada approves clinical trial for two experimental drugs for HIV

Hopital National St. Maurice - HIV and STI risk factors identified for men who have sex with men in Senegal

India National Center for Cell Science, Maharashtra - Hsp40 necessary for HIV-1 Nef-mediated enhancement of viral gene expression and replication

Institute Salud Carlos III, Madrid - Novel HIV-1 circulating AIDG intersubtype recombinant form is identified in Cuba

International Medical Center of Japan - Oligopeptide from HIV-1 Vpr improves gene expression in resting macrophages

Johns Hopkins Bloomberg School of Public Health - Subcutaneous IL-2 positively impacts long-term quality of life in HIV/AIDS

Karolinska Institute - IL-7R alpha loss associated with CD4 T-cell depletion and high IL-7 in HIV/AIDS

Kripa Rehabilitation Center, Maharashtra - HIV/AIDS patients in Mumbai experience discrimination in healthcare settings

Leiden University - HIV entry inhibitor TAK-779 attenuates atherogenesis in LDL receptor deficiency

Medical Research Council Clinical Trials Unit, London - Dextrin sulphate against HIV is well tolerated without systemic absorption

Montefiore Medical Center, Bronx - Low androgen level in older men is associated with acquisition of HIV infection

MRC, London - Total lymphocyte count predicts disease progression risk in pediatric HIV/AIDS

Ohio State University - Regulatory link discovered between muscular dystrophy and cancer cachexia

Rockefeller University, New York - Enhanced antigenemia during chronic SIV infection may augment virus-specific immunity

Samaritan Pharmaceuticals Inc. - Drug developer kicks off second phase II monotherapy trial to further study antiHIV drug